These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25329491)

  • 1. Comorbidity effects on cocaine dependence treatment and examination of reciprocal relationships between abstinence and depression.
    Milby JB; Conti K; Wallace D; Mennemeyer S; Mrug S; Schumacher JE
    J Consult Clin Psychol; 2015 Feb; 83(1):45-55. PubMed ID: 25329491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contingency management targeting abstinence is effective in reducing depressive and anxiety symptoms among crack cocaine-dependent individuals.
    Miguel AQC; Madruga CS; Cogo-Moreira H; Yamauchi R; Simões V; Ribeiro A; da Silva CJ; Fruci A; McDonell M; McPherson S; Roll JM; Laranjeira RR
    Exp Clin Psychopharmacol; 2017 Dec; 25(6):466-472. PubMed ID: 29251975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.
    McDowell D; Nunes EV; Seracini AM; Rothenberg J; Vosburg SK; Ma GJ; Petkova E
    Drug Alcohol Depend; 2005 Nov; 80(2):209-21. PubMed ID: 15913920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and Effectiveness of Treating Homeless Persons with Cocaine Addiction with Alternative Contingency Management Strategies.
    Mennemeyer ST; Schumacher JE; Milby JB; Wallace D
    J Ment Health Policy Econ; 2017 Mar; 20(1):21-36. PubMed ID: 28418835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of depressive symptoms during abstinence with the subjective high produced by cocaine.
    Uslaner J; Kalechstein A; Richter T; Ling W; Newton T
    Am J Psychiatry; 1999 Sep; 156(9):1444-6. PubMed ID: 10484960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contingency management improves outcomes in cocaine-dependent outpatients with depressive symptoms.
    García-Fernández G; Secades-Villa R; García-Rodríguez O; Peña-Suárez E; Sánchez-Hervás E
    Exp Clin Psychopharmacol; 2013 Dec; 21(6):482-9. PubMed ID: 24080020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression among cocaine abusers in treatment: relation to cocaine and alcohol use and treatment outcome.
    Brown RA; Monti PM; Myers MG; Martin RA; Rivinus T; Dubreuil ME; Rohsenow DJ
    Am J Psychiatry; 1998 Feb; 155(2):220-5. PubMed ID: 9464201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short and long-term improvements in psychiatric symptomatology to validate clinically meaningful treatment outcomes for cocaine use disorders.
    Miguel AQC; Kiluk BD; Babuscio TA; Nich C; Mari JJ; Carroll KM
    Drug Alcohol Depend; 2019 May; 198():126-132. PubMed ID: 30921648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of co-occurring depression on treatment for anxiety disorders: analysis of outcomes from a large primary care effectiveness trial.
    Campbell-Sills L; Sherbourne CD; Roy-Byrne P; Craske MG; Sullivan G; Bystritsky A; Lang AJ; Chavira DA; Rose RD; Shaw Welch S; Stein MB
    J Clin Psychiatry; 2012 Dec; 73(12):1509-16. PubMed ID: 23290323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptoms of anhedonia, not depression, predict the outcome of treatment of cocaine dependence.
    Crits-Christoph P; Wadden S; Gaines A; Rieger A; Gallop R; McKay JR; Gibbons MBC
    J Subst Abuse Treat; 2018 Sep; 92():46-50. PubMed ID: 30032944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between anxiety levels and outcome of cocaine abuse treatment.
    O'Leary TA; Rohsenow DJ; Martin R; Colby SM; Eaton CA; Monti PM
    Am J Drug Alcohol Abuse; 2000 May; 26(2):179-94. PubMed ID: 10852355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The autonomy of mood disorders among cocaine-using methadone patients.
    Rosenblum A; Fallon B; Magura S; Handelsman L; Foote J; Bernstein D
    Am J Drug Alcohol Abuse; 1999 Feb; 25(1):67-80. PubMed ID: 10078978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apathy syndrome in cocaine dependence.
    Kalechstein AD; Newton TF; Leavengood AH
    Psychiatry Res; 2002 Jan; 109(1):97-100. PubMed ID: 11850056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Psychosocial Factors on Success Rates of Hepatitis C Treatment.
    Janda M; Mergenhagen KA
    Psychosomatics; 2017; 58(6):624-632. PubMed ID: 28870488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Substance use, affective problems and personality traits: test of two association models].
    Chakroun N; Doron J; Swendsen J
    Encephale; 2004; 30(6):564-9. PubMed ID: 15738859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderating effect of comorbid anxiety disorders on treatment outcome in a randomized controlled psychotherapy trial in early-onset persistently depressed outpatients.
    Assmann N; Schramm E; Kriston L; Hautzinger M; Härter M; Schweiger U; Klein JP
    Depress Anxiety; 2018 Oct; 35(10):1001-1008. PubMed ID: 30199128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric and substance-use comorbidities associated with lifetime crack cocaine use in young adults in the general population.
    Narvaez JC; Jansen K; Pinheiro RT; Kapczinski F; Silva RA; Pechansky F; Magalhães PV
    Compr Psychiatry; 2014 Aug; 55(6):1369-76. PubMed ID: 24933652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidity Profiles of Psychotic Patients in Emergency Psychiatry.
    Lecomte T; Giguère CÉ; Cloutier B; Potvin S;
    J Dual Diagn; 2020; 16(2):260-270. PubMed ID: 31983294
    [No Abstract]   [Full Text] [Related]  

  • 19. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
    Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
    Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressive and anxiety disorders in women with HIV infection.
    Morrison MF; Petitto JM; Ten Have T; Gettes DR; Chiappini MS; Weber AL; Brinker-Spence P; Bauer RM; Douglas SD; Evans DL
    Am J Psychiatry; 2002 May; 159(5):789-96. PubMed ID: 11986133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.